Earnings Date
Oct 26
EPS
$2.330
Quarterly Revenue
$632.1M
Annual Revenue (as of Sep 30)
$2.7B
Earnings History
Analyze the earnings history of Bio-Rad Laboratories using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/15/2024 | PM | BIO | Q4 | $3.31 | — | — | — | $730.29M | — | — | — | Get Alert |
| 10/26/2023 | PM | BIO | Q3 | $2.64 | $2.78 | $2.33 | -16.19% | $680.80M | $689.57M | $632.12M | -8.33% | Get Alert |
| 08/03/2023 | PM | BIO | Q2 | $3.38 | $2.55 | $3.00 | 17.65% | $691.10M | $687.88M | $681.10M | -0.99% | Get Alert |
| 05/04/2023 | PM | BIO | Q1 | $4.94 | $3.54 | $3.34 | -5.65% | $700.06M | $689.83M | $676.84M | -1.88% | Get Alert |
| 02/16/2023 | PM | BIO | Q4 | $3.21 | $3.45 | $3.31 | -4.06% | $732.77M | $742.25M | $730.29M | -1.61% | Get Alert |
| 10/27/2022 | PM | BIO | Q3 | $3.71 | $2.78 | $2.60 | -6.47% | $715.20M | $679.94M | $680.80M | 0.13% | Get Alert |
| 07/28/2022 | PM | BIO | Q2 | $3.54 | $2.80 | $3.38 | 20.71% | $715.93M | $682.62M | $691.10M | 1.24% | Get Alert |
| 04/28/2022 | PM | BIO | Q1 | $5.21 | $3.40 | $4.94 | 45.29% | $726.80M | $675.10M | $700.06M | 3.70% | Get Alert |
| 02/10/2022 | PM | BIO | Q4 | $4.01 | $2.85 | $3.21 | 12.63% | $789.84M | $731.98M | $732.77M | 0.11% | Get Alert |
| 10/28/2021 | PM | BIO | Q3 | $3.00 | $2.44 | $3.71 | 52.05% | $647.26M | $661.87M | $715.20M | 8.06% | Get Alert |
| 07/29/2021 | PM | BIO | Q2 | $1.61 | $2.66 | $3.54 | 33.08% | $536.88M | $631.78M | $715.93M | 13.32% | Get Alert |
| 04/29/2021 | PM | BIO | Q1 | $1.91 | $3.00 | $5.21 | 73.67% | $571.64M | $660.98M | $726.80M | 9.96% | Get Alert |
| 02/11/2021 | PM | BIO | Q4 | $2.32 | $3.29 | $4.01 | 21.88% | $624.43M | $686.80M | $789.84M | 15.00% | Get Alert |
| 10/29/2020 | PM | BIO | Q3 | $1.61 | $1.80 | $3.00 | 66.67% | $560.63M | $570.58M | $647.26M | 13.44% | Get Alert |
| 07/30/2020 | PM | BIO | Q2 | $1.57 | $1.15 | $1.61 | 40.00% | $572.62M | $503.82M | $536.88M | 6.56% | Get Alert |
| 05/06/2020 | PM | BIO | Q1 | $1.65 | $1.61 | $1.91 | 18.63% | $553.98M | $554.89M | $571.64M | 3.02% | Get Alert |
| 02/13/2020 | PM | BIO | Q4 | $2.13 | $2.44 | $2.32 | -4.92% | $617.54M | $641.95M | $624.43M | -2.73% | Get Alert |
| 10/31/2019 | PM | BIO | Q3 | $0.91 | $1.40 | $1.61 | 15.00% | $545.14M | $565.03M | $560.63M | -0.78% | Get Alert |
| 08/01/2019 | PM | BIO | Q2 | $1.64 | $1.33 | $1.57 | 18.05% | $575.91M | $566.19M | $572.62M | 1.14% | Get Alert |
When is Bio-Rad Laboratories (NYSE:BIO) reporting earnings?
Bio-Rad Laboratories (BIO) is scheduled to report earnings on February 15, 2024. The last reported earnings were for reported on October 26, 2023 for Q3.
What were the latest earnings per share (EPS) for Bio-Rad Laboratories (NYSE:BIO)?
The Actual EPS was $2.33, which missed the estimate of $2.78.
What were Bio-Rad Laboratories’s (NYSE:BIO) revenues?
The Actual Revenue was $632.1M, which missed the estimate of $689.6M.
Browse earnings estimates, EPS, and revenue on all stocks.